OBAIR Air Conditioning teams up with Future Pharmaceutical to jointly depict a new paradigm of green pharmaceutical enterprises.

Under the "Dual Carbon" background, the pharmaceutical industry faces pressure to reduce carbon emissions, where energy conservation and carbon reduction in the HVAC system are key. OBAIR Air Conditioning, as an expert in pharmaceutical air treatment, adheres to the ESG concept and offers green and low-carbon solutions for pharmaceutical enterprises. Xuchang Future Pharmaceutical Co., Ltd. covers 150 acres and is a modern large-scale pharmaceutical company. OBAIR provided it with efficient equipment like the integrated evaporative cooling screw chiller, which combines multiple functions, is energy-efficient and easy to install, with better energy efficiency than the national first-level standard. Also included are air-cooled modular cold and hot water units and ZKW series combined air conditioning units, meeting the demands of high-quality production environments. With its technical edge in biopharmaceuticals, OBAIR has served numerous medical and pharmaceutical projects and cooperated with over 5,000 pharmaceutical companies and research institutes. In the future, it will keep leveraging its strengths, update products and solutions, create a favorable production environment for pharmaceutical companies, boost the high-quality and sustainable development of the industry, and assist pharmaceutical enterprises in green upgrading and transformation, taking firm steps in carbon reduction. This is the content reduced to around 400 words. You can adjust it according to the actual situation. If you have any further questions, feel free to ask me.